Clinical Trial Update: Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study [Phase 2, Phase 3]

View source ↗

Summary

A proof-of-concept study assessing praziquantel for treatment of female genital schistosomiasis (FGS) in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Praziquantel (Praziquantel)

Snippet

Sponsor: Regionshospital Nordjylland | Conditions: Schistosomiasis | Phase 2, Phase 3 | Status: COMPLETED